TNF and LTA genes of 435 ethnic Thais who had subclinical DENV infection, primary or secondary dengue fever (DF), or primary or secondary dengue hemorrhagic fever (DHF). The TNF ؊238A polymorphism marking the TNF-4,LTA-3 haplotype occurred in a significantly greater number of patients with secondary DHF (20 [15.2%] of 132) than patients with secondary DF (7 [4.1%] of 169) (P<.001; P corrected by use of Bonferroni adjustment, .022; odds ratio, 4.13 [95% confidence interval, 1.59 -11.17]). In a subset of patients, the LTA-3 haplotype was associated with in vivo intracellular production of LT-␣ and TNF-␣ during the acute viremic phase of infection. Two extended human major histocompatibility complex (MHC) haplotypes containing TNF-4 and LTA-3, together with HLA-B48, HLA-B57, and HLA-DPB1*0501, were detected only in patients with secondary DHF. These observations indicate that polymorphism in functionally distinct MHC-encoded proteins contributes to the risk of developing severe secondary DENV infection and warrants further investigation.
Severe dengue virus (DENV) infection is characterized by a cascade of cytokine production, including the production of tumor necrosis factor-␣ (TNF-␣) and lymphotoxin-␣ (LT-␣). We have analyzed a variety of polymorphisms in the
Dengue virus (DENV) infection is an important cause of morbidity and mortality in tropical and subtropical regions including mainland Southeast Asia, with worldwide prevalence estimates of up to 100 million infections each year [1] . Human infection can be subclinical or it can manifest as self-limiting febrile dengue fever (DF) or the more severe, life-threatening dengue hemorrhagic fever (DHF) [2] . Illness can occur during either primary or secondary infection, although most patients who develop DHF are undergoing secondary infection with a virus serotype heterologous to the type involved in their previous exposure [3] . DHF is characterized by increased capillary permeability, which results in leakage of plasma and has the potential to culminate in hemorrhage, circulatory shock, and death. It has been proposed that DHF in patients with secondary DENV infection is the immunopathological consequence of the overproduction of various cytokines or chemical mediators [4] . Previous studies have shown increased serum and plasma levels of cytokines, including tumor necrosis factor-␣ (TNF-␣) and lymphotoxin-␣ (LT-␣), in patients with DENV infection [5] [6] [7] [8] . Relatively higher levels of TNF-␣ and LT-␣ have been detected in ethnic Thai patients with DHF, compared with patients with DF; peak levels occurred around the period of crisis when plasma leakage, hemorrhage, and circulatory shock commonly occur in patients with DHF [7, 8] .
TNF-␣ and LT-␣ are pleuripotent vasoactive immunomodulators produced mainly by activated monocytes and lymphocytes, respectively. TNF-␣ and LT-␣ share the same receptors [9] as well as many biological activities, and they are central mediators of the immune response [10] . Both TNF-␣ and LT-␣ are encoded by adjacent gene loci in the central or class III region of the human major histocompatibility complex (MHC), between the HLA class I and II genes on the short arm of chromosome 6 [11] . TNF-␣ and LT-␣ share ϳ50% homology in their amino acid composition. As with all eukaryotic genes, TNF and LTA expression is controlled by a series of cis-encoded nucleotide promoter motifs and trans-acting protein factors [12] [13] [14] . A variety of single-nucleotide polymorphisms (SNPs) have been identified in noncoding promoter-like regions adjacent to exons that encode TNF-␣ and LT-␣ [15] . Furthermore, linkage disequilibrium between TNF, LTA, and other HLA class I and II genes in the MHC contributes to the formation of haplotypes or stable combinations of SNP-defined alleles that vary in composition and frequency, both within and between different ethnic groups [15] [16] [17] .
Case-control studies in a variety of populations have revealed associations between putative TNF promoter polymorphisms and malaria [12, 18] , leishmaniasis [19] , leprosy [20] , typhoid fever [21] , and hepatitis B and C [22, 23] . To date, the analysis of TNF gene associations with DENV infection has been limited. A case-control study of Vietnamese patients with DHF identified no significant associations [24] . By contrast, another smaller study that involved Venezuelan patients revealed an increased frequency of a putative TNF promoter polymorphism in patients with DHF [25] . The purpose of our current study was to examine SNP-defined TNF and LTA haplotype profiles in the following 5 cohorts of ethnic Thais: individuals with subclinical DENV exposure, individuals with primary or secondary DF, and individuals with primary or secondary DHF.
PATIENTS, MATERIALS, AND METHODS
Patients and control subjects. Unrelated ethnic Thai children with serologically and virologically confirmed DENV infections who were between the ages of 3 and 14 years and weighed Ͼ20 kg were enrolled in 2 clinical studies, as described elsewhere [26] . Clinical diagnoses of DF and DHF were assigned by an expert physician reviewer, guided by World Health Organization (WHO) criteria [2] . A total of 228 patients were diagnosed with DF, and 142 patients were diagnosed with DHF. DHF was fur-ther classified by severity according to the WHO criteria [2] . Serological responses to DENV were measured by both EIA and hemagglutination inhibition test. Primary or secondary infection was diagnosed on the basis of the ratio of DENV-specific IgM and IgG serum antibodies and the titer of hemagglutination inhibition antibodies, in accordance with WHO guidelines [2] . DENV serotypes (DENV-1, DENV-2, DENV-3, and DENV-4) were identified by isolation in Toxorhynchites splendens mosquitoes and reverse-transcriptase polymerase chain reaction (PCR), as described elsewhere [27] [28] [29] . A total of 65 children were identified as having subclinical DENV infection, which was indicated by increases in DENV-specific antibody titers without recognized illness, as described elsewhere [29] . One hundred fortythree unrelated, ethnically matched, healthy Thais were used as control subjects.
Analysis of TNF and LTA polymorphisms. Full-length genomic DNA was isolated, as described elsewhere [30] . The PCR sequence-specific primer (SSP) or phototyping method described by Fanning et al. [15] was used to identify TNF polymorphisms at positions Ϫ308 (G/A), Ϫ238 (G/A), and ϩ488 (G/A), as well as LTA polymorphisms at positions ϩ249 (A/G), ϩ365 (G/C), and ϩ720 (C/A) . This method employs 24 primer pairs to define cis-encoded polymorphisms at the positions mentioned above, with modifications (indicated by underlining) made to primers 708 (5'-ATAGGTTTTGAGGGGCATGG-3') and 709 (5'-ATAGGTTTTGAGGGGCATGA-3'). PCR products were separated with electrophoresis (20 min at 200 V/cm 2 ) in 1% agarose gel containing ethidium bromide, and digital images of each gel were recorded under UV illumination. The presence of a polymorphism-specific product of the expected size [15] , in conjunction with an internal PCR control product, was considered to be a positive result. The frequency for the cis-encoded TNF and LTA polymorphisms that define the haplotypes TNF-1, TNF-2, TNF-3, and TNF-4, as well as LTA-1, LTA-2, and LTA-3 [15] were determined by use of the following formula: haplotype frequency ϭ (n/N) ϫ 100, where n is the number of individuals who were positive for a given haplotype and N is the total number of individuals who were genotyped in the patient or control group. All of the DENV-exposed patients with subclinical infection and clinical infection (n ϭ 435) and the control subjects (n ϭ 143) were genotyped for TNF. In addition, 361 clinical case patients were genotyped for LTA, as were all the control subjects. HLA class I and II allele profiles were also determined for selected case patients and control subjects by use of both serological and molecular methods, and the results were defined using the standard WHO-recognized system of nomenclature for HLA serotypes and genotypes [26, 30, 31] .
Immunocytochemical staining of TNF-␣ and LT-␣. Seventeen of the case patients in this study had previously been included in a study of cytokine-producing cells in peripheral blood [6] . A subset of patients with DF and DHF were selected at random, and TNF-␣-specific and LT-␣-specific monoclonal antibodies were used to determine the presence and relative proportions of cytokine-producing peripheral blood mononuclear cells (PBMCs) [8] . In brief, blood samples were obtained daily from DENVinfected patients during the febrile period, after defervescence, and during the early convalescent phase 5-8 days after defervesescence. PBMCs were cryopreserved and stored in liquid nitrogen. Cells were thawed, and cytospin preparations were produced prior to the identification and enumeration of TNF-␣-producing and LT-␣producing cells by use of immunocytochemical staining and light microscopy [8] . The range of cells scoring positive for TNF-␣ production was 3-219 cells per 10 6 PBMCs and 3-27 cells per 10 6 PBMCs for LT-␣ production, with peak scores occurring mainly during the immediate defervescence period.
Statistical analysis. Hardy-Weinberg equilibrium tests were performed for all TNF and LTA SNPs in all groups of case patients and control subjects, as described elsewhere [32] , and all SNPs were found to be in equilibrium except the TNF Ϫ308 polymorphism in the group of patients with secondary DHF (data not shown). A variety of TNF and LTA haplotype frequencies were compared between case patients and control subjects by using the 2 test for heterogeneity (2 ϫ 2 contingency tables); Yates's correction was applied when necessary, and Fisher's exact test was used when the sum of adjacent fields was Ͻ10. P Ͻ.05 was considered significant, and P values were corrected by use of Bonferroni adjustment (P c ) for random haplotype associations depending on the number of comparisons made, which included the number of TNF and LTA haplotypes identified (4 and 3, respectively), the total number of case patient and control subject groups (n ϭ 6), and the number of TNF and LTA haplotype combinations (n ϭ 12) or profiles (n ϭ 24) detected. P c Ͻ.05 was considered highly significant. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the risk of disease severity associated with specific TNF or LTA haplotypes. A posteriori power calculations were also performed for all case patient and control subject groups by using the Power and Sample Size (PS) and Power for Genetic Association Analyses (PGA) software programs [33] .
RESULTS

TNF and LTA haplotypes in control subjects and DENVinfected case patients.
Using the PCR-SSP typing method described by Fanning et al [15] , which employs a series of short-range amplifications to unambiguously identify cis-encoded polymorphisms, we were able to determine the frequency for 4 combinations, or haplotypes, of TNF polymorphisms in the case patient and control subject groups (table 1). The TNF-3 haplotype, which is characterized by a G-to-A substitution at position ϩ488, had a significantly decreased frequency in patients with primary DF, compared with its frequency in patients with subclinical infection, in patients with secondary DF, and in the control subjects (table 1) . However, the most significant association we observed was with the TNF-4 haplotype (characterized by a unique G-to-A substitution at position Ϫ238), which was substantially increased in patients with secondary DHF, compared with patients with secondary DF (P c Ͻ .05) or healthy control subjects (P Ͻ .05) (table 1) . This association was not apparent in patients with primary DENV infections (table 1), but was evident when all patients with both primary and secondary DHF were compared with the combined DF groups ( 2 ϭ 8.7; P ϭ .003; P c ϭ .048; OR, 2.9 [95% CI, 1.32-6.32]) or control groups ( 2 ϭ 4.5; P ϭ .04; P c ϭ NS; OR, 2.3 [95% CI, 0.99 -5.5]), but of relatively lower significance than the associations observed in patients with secondary infections alone (table 1), indicating that this haplotype's major association is with secondary DHF. By contrast, the analysis of LTA polymorphisms in which we used the method described by Fanning et al. [15] revealed the presence of 3 LTA haplotypes but showed no associations between these haplotypes and any of the DENV-infected patient groups (table 2) . Nevertheless, linkage disequilibrium between the TNF-4 and LTA-3 haplotypes was evident. Of the subjects genotyped for both TNF and LTA, all but one of those who carried TNF-4 also carried the LTA-3 haplotype. Thus individuals positive for TNF-4,LTA-3 were observed significantly more frequently among patients with secondary DHF (17 [13.2%] of 129) than among patients with secondary DF (6 [3.7%] of 163) ( 2 ϭ 9.0; P ϭ .003; P c ϭ .034; OR, 4.0 [95% CI, 1.4 -11.7]). We also stratified our data for the viral serotypes that caused the infections (DENV-1, DENV-2, DENV-3, and DENV-4), but found no associations with any TNF or LTA haplotypes (data not shown).
LTA haplotypes correlate with in vivo LT-␣ and TNF-␣ production. Seventeen patients who were genotyped for TNF and LTA (9 patients with DF and 8 with DHF) had previously been assessed for intracellular production of TNF-␣ and LT-␣ during the acute viremic phase of infection [8] . Therefore, we were able to compare TNF and LTA haplotype profiles with the known presence or absence of cytokine production in these patients. No significant associations were detected between intracellular cytokine production and any TNF haplotype (data not shown). However, the LTA-3 haplotype was associated with detectable LT-␣ and TNF-␣ production (P Ͻ .05) (table 3) . By contrast, the LTA-2 haplotype correlated with a lack of TNF-␣ production (P Ͻ .05) (table 3) , but not LT-␣ production (data not shown). (table 1) , the linkage disequilibrium between TNF-4 and LTA-3 haplotypes [15] , and the correlation between LTA-3 and both LT-␣ and TNF-␣ production (table 3), we stratified our TNF and LTA haplotype combinations or profiles (n ϭ 24) and compared these with disease severity in patients with secondary DENV infections. Two profiles, namely TNF-1,4;LTA-1,3 and TNF-1,4;LTA-3,3, were detected in patients with secondary DHF (10 [7.8%] of 129) and control subjects (3 [2.1%] of 143), but these profiles were entirely absent from patients with secondary DF (patients with secondary DHF vs. patients with secondary DF: 2 ϭ 13.1, P Ͻ .001, P c ϭ .014).
Long-range extended TNF, LTA, and HLA class I and II haplotypes in patients with secondary DHF. Given the association between TNF-4 and disease severity in patients with secondary DENV infections
We also determined the HLA class I and II alleles present in patients with secondary DHF who had the TNF-1,4;LTA-1,3 or TNF-1,4;LTA-3,3 haplotype profile (table 4) . Five patients carried the HLA-B48 allele, which is relatively rare in Southeast Asian populations [30] (see the Allele Frequencies in Worldwide Populations database at http://www.allelefrequencies.net). Our previous analyses of HLA class I alleles in the same cohorts of dengue virus-infected Thais excluded alleles that occurred relatively infrequently, such as HLA-B48 [26] . However, we have now recalculated the frequency for HLA-B48 in all patients with secondary DHF (8 [5.2%] of 154) and control subjects (4 [1.9%] of 216) who have been HLA class I-typed to date. By comparison, HLA-B48 was not detected in any of the patients with secondary DF (patients with secondary DHF vs. patients with secondary DF: 2 ϭ 10.3, P Ͻ .001, P c Ͻ .035). A further 4 patients shown in table 4 also carried HLA-B57, which forms an extended haplotype with the HLA NOTE. Data are no. of patients with the given LTA haplotype/total no. of patients positive or negative for either intracellular lymphotoxin-␣ (LT-␣) or tumor necrosis factor-␣ (TNF-␣) cytokine production. None of the corrected P values were significant (P c Ͼ .05).
class II alleles DRB1*0701 and DQB1*03032. The most frequent HLA class II allele detected in the patients with secondary DHF shown in table 4 was DPB1*0501, which is relatively common in Southeast Asians [31] .
DISCUSSION
Human genomic SNP typing is proving to be a powerful tool in disease association studies. Its application to large cohorts of DENV-infected Thai patients has revealed significant functional allelic differences between patients with DF and patients with DHF in gene loci such as CD209, which encodes a DENV receptor (dendritic cell-specific intercellular adhesion molecule-3grabbing nonintegrin-1) [34] . Likewise, we have previously been able to identify significant associations between certain HLA class I alleles and disease severity in Thais with secondary DENV virus infection [26] . We have now extended our analysis of the human MHC in ethnic Thais to the central or class III region and can confirm that there are considerable similarities between Thai TNF and LTA gene profiles and those reported in other mainland Southeast Asian populations [21] . For example, the polymorphisms that characterize the TNF-2 (Ϫ308A), TNF-4 (Ϫ238A), and LTA-2 (ϩ249G) haplotypes [15] all occur in the major Kinh population of Vietnam at rates nearly equivalent to those observed in the Thai control subjects involved in the present study [21] (tables 1 and 2). These observations are also consistent with previous analyses of HLA class I and II genes in Thais, which have shown this major ethnic group to be strongly representative of the large and diverse populations of mainland Southeast Asia [26, 30, 31] .
A previous study of the TNF Ϫ238G/A and Ϫ308G/A polymorphisms in Vietnamese patients with DHF whose infections were not distinguished as primary or secondary revealed no associations with disease when compared with results for control subjects from the same population [24] . Our study focused on a Thai cohort stratified for subclinical DENV infection, primary or secondary clinical infection, and disease severity (tables 1 and 2). In these groups, which were of sufficient size to achieve 80% power to detect differences in haplotype frequency of 11%-21% (P Ͻ .05) in all but the group of patients with primary DHF (data not shown), we have identified a significant association between the TNF-4 haplotype (Ϫ238A) and disease severity in patients with secondary DENV infection (table 1). Given that the Vietnamese and Thai populations reside in close proximity in a region where all 4 major DENV serotypes are in seasonal circulation, these apparently inconsistent TNF allele associations with DHF in 2 genetically similar ethnic groups are most likely the result of differences in study design [24, 26] (table 1) .
By contrast, a preponderance of TNF Ϫ308A has been reported in a relatively smaller study of Venezuelan patients with DHF [25] . The TNF Ϫ308A allele is part of the TNF-2 haplotype as defined by 3 SNPs in our study; however, it occurred at very similar frequencies in the patient and control groups (table 1), which excludes this allele from association with DHF in ethnic Thais, similar to what has been reported for other mainland Southeast Asians [24] . Nevertheless, any study of highly polymorphic genes, such as those encoded within the human MHC, is fraught with the possibility of random effects confounding observed disease associations [35] . Thus, it is imperative that studies be of sufficient size and power, as well as corrected to exclude confounding factors-as in the current study-and the results should be confirmed in other cohorts of DENV-exposed patients. [2] . Bold type indicates either single-nucleotide polymorphism-defined TNF and LTA haplotype profiles detected only in patients with secondary DHF or relatively rare HLA alleles and haplotypes associated with null expression of MHC-encoded proteins [38, 41] .
The Ϫ238A polymorphism that characterizes the TNF-4 haplotype has been detected in European [15] [16] [17] , African [16] , Amerindian [16] , and Asian populations [16, 21] . There is no clear evidence that the TNF Ϫ238A polymorphism directly affects TNF-␣ production, although it is located near a putative gene repressor site [36] . The TNF Ϫ238A allele has been significantly associated with other infections, such as hepatitis C [22] , hepatitis B [22] , and severe malarial anemia [37] . However, the latter association with malaria is probably secondary to the presence of another linked TNF polymorphism (Ϫ376A), which augments TNF-␣ secretion by recruiting octamer-binding transcription factor-1 [13] . We did not analyze polymorphisms at TNF position Ϫ376 in our study, although most individuals who carry the TNF Ϫ376A allele also tend to have the Ϫ238A allele, at least in African and European populations [13, 37] .
In contrast to our previous studies of HLA class I polymorphisms in ethnic Thais [26] , we were unable to identify any association between polymorphisms in the TNF or LTA genes and the specific DENV serotype causing the infection for either primary or secondary infection (data not shown). Nevertheless, we observed another significant association, albeit a less robust one, in which the TNF-3 (ϩ488A) haplotype occurred at a reduced frequency in patients with primary DF (table 1) . This haplotype could be part of, or in linkage disequilibrium with, a gene locus that is protective against the development of clinical disease during primary DENV exposure, hence the relatively high frequency for TNF-3 in the cohort of patients with subclinical DENV infection (table 1) .
The TNF-4 haplotype has been shown to be in strong linkage disequilibrium with LTA-3 in whites [15] . Similarly, all but one of the subjects in the present study who carried TNF-4 also carried LTA-3. However, none of the LTA haplotypes (including LTA-3) showed a significant association with any of our DENVinfected patient groups (table 2) . Nevertheless, the presence of the LTA-3 haplotype correlated with in vivo production of both LT-␣ and TNF-␣, as measured by immunostaining of PBMCs in a relatively small subset of our patient cohort (table 3) . Most previous studies have examined the effect of TNF and LTA polymorphisms in vitro, by measuring mitogen-induced cytokine production [12] [13] [14] . By contrast, our approach provides a rare insight into the association of host TNF and LTA haplotypes with in vivo production of cytokines during the acute viremic phase of DENV infection (table 3) and warrants further investigation in a larger cohort of patients genotyped for TNF and LTA.
Two combinations of TNF-4,LTA-3 haplotypes were detected only in patients with secondary DHF (table 4). A striking feature of these haplotypes was the prevalence of the HLA class I alleles HLA-B48 and HLA-B57 (table 4) , which occur at relatively low frequencies in ethnic Thais [30] . Both HLA-B48 and HLA-B57 are known to be in linkage disequilibrium with the TNF Ϫ238A allele on the TNF-4 haplotype [16] . HLA-B48 occurs predominantly in Asian and Amerindian populations, but is virtually absent from Africans and whites (see http://www.allelefrequencies.net). HLA-B48 is also associated with a gross deletion of the nonclassical MHC class I chain-related (MIC) gene loci adjacent to HLA-B in the human MHC [38] , which encode target ligands for NK cells by using the ubiquitous activatory lectin-like receptor NKG2D [39] . NK cells have a variety of immunoregulatory and antiviral activities, and activation of NK cells is a feature of DENV infection in our ethnic Thai cohort [40] . Similarly, HLA-B57, which occurred in 9 (4.2%) of 216 of our Thai control subjects [30] , forms a stable haplotype with the allelic products of at least 3 other class II gene loci, namely DRB1*0701, DRB4*0301N, and DQB1*03032 [41] . DRB4*0301N is a defective class II allele with a complete abrogation of gene expression, resulting in the HLA-DR53 null phenotype [41] . Thus, the TNF-4 and LTA-3 haplotype profiles that contain either HLA-B48 or B57, which are associated exclusively with severe clinical disease after secondary DENV infection (table 4) , are also associated with null expression variants of other gene loci within the MHC.
HLA-B48 is also one of the few class I molecules that are polymorphic in the third extracellular (␣-3) protein domain. This is the domain that makes contact with the human CD8 coreceptor that facilitates the recognition of antigens bound to HLA class I molecules by the T cell receptor (TCR). Threonine at position 245 of HLA-B48 replaces the standard alanine found in most HLA-B alleles (see the International Immunogenetics Project HLA database at http://www.ebi.ac.uk/imgt/hla) and greatly reduces the binding of HLA-B48 to CD8, compared with alleles that have Ala245 [42] . A possible consequence of this effect is that HLA-B48 -restricted TCRs might have evolved increased antigen-binding permissiveness to compensate for CD8's poor stabilization of the TCR-HLA-B48 complex. If this were the case, then secondary dengue virus infection in individuals positive for HLA-B48 might result in an expanded potential for cross-reactive DENV serotype responses.
In conclusion, our analysis of SNP-defined TNF and LTA haplotype profiles in a cohort of dengue virus-exposed Thais has revealed TNF-specific polymorphisms that are associated with severe clinical complications in patients with secondary infection (table 1). We have evidence to suggest that certain LTA haplotypes are associated with in vivo LT-␣ and TNF-␣ production during the acute viremic phase of dengue virus infection. We have also detected linkage disequilibrium between the TNF locus and the LTA locus that extends into the class I and II regions of the human MHC in ethnic Thais. Furthermore, some extended haplotypes that contain relatively rare HLA class I alleles, as well as HLA class II null expression variants and deletions of the nonclassical MIC loci, are uniquely associated with secondary DHF (table 4 ). These observations suggest that a variety of gene products encoded in the human MHC may act together to determine disease outcome in immunologically primed individuals who undergo secondary exposure to DENV, and these results are worthy of further investigation. 
